June 29 (Reuters) - A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.
from Reuters: Company News https://ift.tt/2Ndnxv9
via IFTTT
0 comments:
Post a Comment